China SXT Pharmaceuticals, Inc. - SXTC

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$487K
QoQ value delta ($000)
+$355K (+268.94%)
Implied price effect (QoQ)
-8.88%
Shares
Total shares
310,838
QoQ shares delta
+234,070 (+304.91%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SXTC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2025)

Top 25 only Full list
Early Q4 2025 data: only 8 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Invesco Ltd. 140 89,660 0.0%
GEODE CAPITAL MANAGEMENT, LLC 85 53,671 0.0%
CITADEL ADVISORS LLC 77 48,759 0.0%
RENAISSANCE TECHNOLOGIES LLC 69 44,500 0.0%
Virtu Financial LLC 46 28,983 0.0%
HRT FINANCIAL LP 42 26,749 0.0%
TWO SIGMA SECURITIES, LLC 24 15,449 0.0%
Tower Research Capital LLC (TRC) 4 2,878 0.0%
UBS Group AG 0 100 0.0%
State of Wyoming 0 89 0.0%